March 10, 2025
With a designation from the FDA, a device created and patented by Flavio Frohlich, PhD, professor of psychiatry at the UNC School of Medicine and member of the UNC Neuroscience Center, is one step closer to being available for patients.
August 26, 2024
Through an analysis of 500+ FDA-authorized AI medical devices, Sammy Chouffani El Fassi, a MD candidate at the UNC School of Medicine and researcher at Duke Heart Center, and Gail E. Henderson, PhD, professor of social medicine at UNC-Chapel Hill, discovered a lack of published clinical validation data for many authorized devices and established a standard for medical AI validation.
July 30, 2024
Vibhor Krishna, MD, a neurosurgeon at the UNC School of Medicine, was one of 15 researchers involved in a multicenter clinical trial showing that bilateral focused ultrasound is safe for patients seeking treatment for essential tremor, including Sally Richey and Frank George, whose stories are below. UNC Hospitals also uses this technology to treat patients with Parkinson’s Disease.
January 3, 2023
Meghan Rebuli, PhD, an assistant professor of pediatrics in the UNC School of Medicine and member of the Center for Environmental Medicine, Asthma, and Lung Biology, shares new findings and recommendations from an expert-led workshop.
November 28, 2018
In this video, UNC School of Medicine toxicologist Ilona Jaspers, PhD, explains the science of inhaling vapor from e-cigarette products and why we should not compare vaping or “juuling” to smoking.
October 20, 2017
UNC School of Medicine researchers lead new study showing that e-cigarettes trigger unique and potentially damaging immune responses in human airways.
March 31, 2010
There was a recent update to the package insert for clopidogrel (Plavix) that includes a black box warning for use in patients who are poor metabolizers.